Aurinia Pharmaceuticals Inc (AUPH)
Equity Ratio
77.61%
Quarterly · Period ending:
AUPH Equity Ratio
Latest reported77.61%period ending
Latest reported77.61%period ending
AUPH Quarterly Equity Ratio (33.33% → 77.61%)
Latest values, visible window
High-resolution chart · PNG
AUPH equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 77.6087% | |
| 78.4017% | |
| 77.3471% | |
| 69.3368% | |
| 66.7183% | |
| 69.3652% | |
| 68.552% | |
| 70.6279% | |
| 69.6458% | |
| 69.5804% | |
| 68.9619% | |
| 70.6068% | |
| 71.4688% | |
| 86.4191% | |
| 86.1052% | |
| 86.7154% | |
| 87.8917% | |
| 88.4043% | |
| 88.1708% | |
| 82.8104% | |
| 86.0172% | |
| 88.7671% | |
| 87.9414% | |
| 86.3764% | |
| 80.9539% | |
| 83.629% | |
| 92.075% | |
| 82.0324% | |
| 83.2257% | |
| 84.7077% | |
| 77.1786% | |
| 79.4838% | |
| 84.6981% | |
| 86.4203% | |
| 87.3035% | |
| 83.8925% | |
| 85.8831% | |
| 78.5925% | |
| 63.0735% | |
| 60.4602% | |
| 64.7287% | |
| 57.7498% | |
| 59.4721% | |
| 60.4422% | |
| 63.1165% | |
| 57.405% | |
| 86.1163% | |
| 87.4475% | |
| 84.8685% | |
| 86.3218% | |
| 57.4733% | |
| 52.4288% | |
| -74.7056% | |
| -80.151% | |
| -50.9425% | |
| 28.5245% | |
| 41.8978% | |
| 63.2191% | |
| 44.7682% | |
| 61.9595% | |
| 55.946% | |
| 39.032% | |
| 61.7367% | |
| 64.5276% | |
| 64.9352% | |
| 59.9816% | |
| 50.3651% | |
| 56.2094% | |
| 66.8259% | |
| 32.4628% | |
| 29.5225% | |
| 40.7185% | |
| 45.3143% | |
| 73.9982% | |
| 66.5965% | |
| 76.6513% | |
| 76.4513% | |
| 81.9671% | |
| 65.8247% | |
| 71.4016% | |
| 76.0458% | |
| 79.2148% | |
| 77.9348% | |
| 85.3297% | |
| 84.7637% | |
| 86.3927% | |
| 85.3314% | |
| 87.9201% | |
| 95.0139% | |
| 92.0854% | |
| 92.0859% | |
| 94.6922% | |
| 94.2852% | |
| 93.8667% | |
| 93.8434% | |
| 94.0898% | |
| 92.1496% | |
| 94.8735% | |
| 86.799% | |
| 89.9036% |